James L. Leenstra

1.2k total citations · 1 hit paper
18 papers, 752 citations indexed

About

James L. Leenstra is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, James L. Leenstra has authored 18 papers receiving a total of 752 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 7 papers in Surgery and 7 papers in Oncology. Recurrent topics in James L. Leenstra's work include Pancreatic and Hepatic Oncology Research (4 papers), Oral health in cancer treatment (4 papers) and Head and Neck Cancer Studies (4 papers). James L. Leenstra is often cited by papers focused on Pancreatic and Hepatic Oncology Research (4 papers), Oral health in cancer treatment (4 papers) and Head and Neck Cancer Studies (4 papers). James L. Leenstra collaborates with scholars based in United States and Netherlands. James L. Leenstra's co-authors include Qian Shi, Wendy L. Frankel, Eileen M. O’Reilly, Spencer C. Behr, Robert Marsh, Joseph M. Herman, Jeffrey A. Meyerhardt, Syed A. Ahmad, Eric A. Collisson and Matthew H. G. Katz and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

James L. Leenstra

18 papers receiving 742 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas

2022 144 citations Matthew H. G. Katz, Qian Shi et al. JAMA Oncology profile →

Peers

Countries citing papers authored by James L. Leenstra

Since Specialization

Citations

This map shows the geographic impact of James L. Leenstra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James L. Leenstra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James L. Leenstra more than expected).

Fields of papers citing papers by James L. Leenstra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James L. Leenstra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James L. Leenstra. The network helps show where James L. Leenstra may publish in the future.

Co-authorship network of co-authors of James L. Leenstra

This figure shows the co-authorship network connecting the top 25 collaborators of James L. Leenstra. A scholar is included among the top collaborators of James L. Leenstra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James L. Leenstra. James L. Leenstra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Establishing the minimal clinically important difference of the Brief Fatigue Inventory for brain or CNS cancer patients undergoing radiotherapy 2024 ·Neuro-Oncology Practice ·(unknown), Isabella Zaniletti, William G. Breen, (unknown), (unknown), Anita Mahajan, Paul D. Brown, Elizabeth Yan, Sujay A. Vora, Kenneth W. Merrell, Jonathan B. Ashman, Jennifer Peterson, James L. Leenstra, (unknown), (unknown), Nadia N. Laack, T.A. DeWees	1
2	Determining the Minimal Clinically Important Difference of the Functional Assessment of Cancer Therapy Hepatobiliary Questionnaire to Evaluate the Change in the Quality of Life of Patients With Pancreatic Cancer During Radiation Therapy 2023 ·International Journal of Radiation OncologyBiologyPhysics ·Isabella Zaniletti, (unknown), Christopher L. Hallemeier, (unknown), (unknown), Michael G. Haddock, Kenneth W. Merrell, James L. Leenstra, (unknown), Jonathan B. Ashman, T.A. DeWees	1
3	Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas breakdown → 2022 ·JAMA Oncology ·Matthew H. G. Katz, Qian Shi, (unknown), Joseph M. Herman, Michael D. Chuong, Brian M. Wolpin, Syed A. Ahmad, Robert Marsh, Lawrence H. Schwartz, Spencer C. Behr, Wendy L. Frankel, Eric A. Collisson, James L. Leenstra, Terence M. Williams, Gina M. Vaccaro, Alan P. Venook, Jeffrey A. Meyerhardt, Eileen M. O’Reilly	144
4	Induction versus no induction chemotherapy before neoadjuvant chemoradiotherapy and surgery in oesophageal adenocarcinoma: a multicentre randomised phase II trial (NCCTG N0849 [Alliance]) 2021 ·European Journal of Cancer ·Harry H. Yoon, Fang‐Shu Ou, Gamini S. Soori, Qian Shi, Dennis A. Wigle, Robert P. Sticca, Robert C. Miller, James L. Leenstra, Patrick J. Peller, Brenda Ginos, Erica N. Heying, Tsung‐Teh Wu, (unknown), Stephen Ko, Bassam Mattar, Daniel A. Nikcevich, Robert J. Behrens, Maged Khalil, George P. Kim, Steven R. Alberts	13
5	Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX plus hypofractionated radiation therapy (RT) for borderline resectable (BR) adenocarcinoma of the pancreas. 2021 ·Journal of Clinical Oncology ·Matthew H. G. Katz, Qian Shi, Jeffrey P. Meyers, Joseph M. Herman, (unknown), Brian M. Wolpin, Syed A. Ahmad, Robert Marsh, Lawrence H. Schwartz, Spencer C. Behr, Wendy L. Frankel, Eric A. Collisson, James L. Leenstra, Terence M. Williams, Gina M. Vaccaro, Alan P. Venook, Jeffrey A. Meyerhardt, Eileen M. O’Reilly	100
6	Linear accelerator-based single-fraction stereotactic body radiotherapy for symptomatic vertebral body hemangiomas: The Mayo Clinic experience 2020 ·Journal of Clinical Neuroscience ·Nathan Y. Yu, Terence T. Sio, Mark Lyons, Sujay A. Vora, (unknown), Paul D. Brown, Sean S. Park, James L. Leenstra, Bernard R. Bendok, Steven E. Schild, Jonathan B. Ashman	7
7	Effect of Doxepin Mouthwash or Diphenhydramine-Lidocaine-Antacid Mouthwash vs Placebo on Radiotherapy-Related Oral Mucositis Pain 2019 ·JAMA ·Terence T. Sio, Jennifer Le‐Rademacher, James L. Leenstra, Charles L. Loprinzi, (unknown), (unknown), Anurag K. Singh, James A. Martenson, Paul J. Novotny, Angelina D. Tan, Rui Qin, Stephen Ko, Paul L. Reiter, Robert C. Miller	52
8	Daily Lisinopril vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial 2018 ·International Journal of Radiation OncologyBiologyPhysics ·Terence T. Sio, Philip J. Atherton, Levi Pederson, (unknown), Robert W. Mutter, Yolanda I. Garces, J. Daniel, James L. Leenstra, Jean-Claude M. Rwigema, Shaker R. Dakhil, James D. Bearden, (unknown), Apar Kishor Ganti, Steven E. Schild, Robert C. Miller	14
9	Data collection of patient outcomes: one institution’s experience 2018 ·Journal of Radiation Research ·Thomas J. Whitaker, Charles S. Mayo, J. Daniel, Michael G. Haddock, Robert C. Miller, Kimberly S. Corbin, M.A. Neben-Wittich, James L. Leenstra, Nadia N. Laack, M. Fatyga, Steven E. Schild, Carlos Vargas, Katherine S. Tzou, (unknown), Steven J. Buskirk, Robert L. Foote	5
10	Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas 2017 ·BMC Cancer ·Matthew H. G. Katz, Fang‐Shu Ou, Joseph M. Herman, Syed A. Ahmad, (unknown), Robert Marsh, Spencer C. Behr, Qian Shi, Michael D. Chuong, Lawrence H. Schwartz, Wendy L. Frankel, Eric A. Collisson, Eugene J. Koay, Joleen M. Hubbard, James L. Leenstra, Jeffrey A. Meyerhardt, Eileen M. O’Reilly	136
11	A Phase III, Randomized Double-Blind Study of Doxepin Rinse versus Magic Mouthwash versus Placebo in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Head and Neck Radiotherapy with or without Chemotherapy (Alliance A221304) 2016 ·International Journal of Radiation OncologyBiologyPhysics ·Robert C. Miller, Jennifer Le‐Rademacher, Terence T. Sio, James L. Leenstra, (unknown), (unknown), Anurag K. Singh, James A. Martenson, (unknown), Angelina D. Tan, Paul L. Reiter, (unknown)	8
12	Doxepin Rinse Versus Placebo in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Head and Neck Radiotherapy With or Without Chemotherapy: A Phase III, Randomized, Double-Blind Trial (NCCTG-N09C6 [Alliance]) 2014 ·Journal of Clinical Oncology ·James L. Leenstra, Robert C. Miller, Rui Qin, James A. Martenson, Kenneth J. Dornfeld, James D. Bearden, Dev R. Puri, Philip J. Stella, Miroslaw Mazurczak, (unknown), Paul J. Novotny, Robert L. Foote, Charles L. Loprinzi	55
13	Randomized phase II trial of extended versus standard neoadjuvant therapy for esophageal cancer, NCCTG (Alliance) trial N0849. 2013 ·Journal of Clinical Oncology ·Steven R. Alberts, Gamini S. Soori, Qian Shi, Dennis A. Wigle, Robert P. Sticca, Robert C. Miller, James L. Leenstra, Patrick J. Peller, Tsung‐Teh Wu, Harry H. Yoon, (unknown), Stephen Ko, Bassam Mattar, Daniel A. Nikcevich, Robert J. Behrens, Maged Khalil, George P. Kim	6
14	N09C6 (Alliance) - A Phase 3, Randomized Double-Blind Study of Doxepin Rinse Versus Placebo in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Head and Neck Radiation Therapy With or Without Chemotherapy 2012 ·International Journal of Radiation OncologyBiologyPhysics ·Robert C. Miller, James L. Leenstra, (unknown), James A. Martenson, Kenneth J. Dornfeld, James D. Bearden, (unknown), Philip J. Stella, Robert L. Foote, (unknown)	3
15	Factors Associated With Endocrine Deficits After Stereotactic Radiosurgery of Pituitary Adenomas 2010 ·Neurosurgery ·James L. Leenstra, Shota Tanaka, Robert W. Kline, Paul D. Brown, Michael J. Link, Todd B. Nippoldt, William F. Young, Bruce E. Pollock	50
16	Validation of a Method for Assessing Resident Physicians’ Quality Improvement Proposals 2007 ·Journal of General Internal Medicine ·James L. Leenstra, Thomas J. Beckman, Darcy A. Reed, William C. Mundell, Kris G. Thomas, Bryan J. Krajicek, S. Stephen, Joseph C. Kolars, Furman S. McDonald	56
17	Prostate Dimensions and Volume in 700 Patients Undergoing Primary Surgical or Radiotherapeutic Management of Localized Adenocarcinoma: Implications for Design of Minimally Invasive Prostate Cancer Devices 2007 ·International Journal of Radiation OncologyBiologyPhysics ·James L. Leenstra, Brian J. Davis, (unknown), Lance A. Mynderse, Michael Herman, David W. Hillman, Katie L. Allen, John C. Cheville, David R. Holmes, Bernard F. King	2
18	Central neurocytoma: Management recommendations based on a 35-year experience 2006 ·International Journal of Radiation OncologyBiologyPhysics ·James L. Leenstra, Fausto J. Rodríguez, (unknown), Caterina Giannini, Scott L. Stafford, Bruce E. Pollock, Steven E. Schild, Bernd W. Scheithauer, Robert B. Jenkins, Jan C. Buckner, Paul D. Brown	99

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact